Drug Trial Radar · NCT06395753
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Aug 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
55
Actual
Start
May 23, 2024
Primary completion
Jun 24, 2026
Study completion Jul 22, 2026
Sponsor
- Lead sponsor
- Debiopharm International SAIndustry
- Sponsor type
- Industry
- First posted
- May 2, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
Conditions
- Prostate Cancer
Interventions
Debio 4228Drug
Administered as IM injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Plasma Concentration (Cmax) of Debio 4228Time frame: Cohorts 1 and 2: Predose and at multiple time points post-dose up to Day 169; Cohort 3: Predose and at multiple time points post-dose up to Day 169
- Area Under the Concentration-time Curve of Debio 4228 Over 12 weeks (AUC84d)Time frame: Cohorts 1 and 2: Predose and at multiple time points post-dose up to Day 84; Cohort 3: Predose and at multiple time points post-dose up to Day 169
- Plasma Concentration of Debio 4228 at Week 12 (C84d)Time frame: Cohorts 1 and 2: Post-dose on Day 84; Cohort 3: Post-dose on Days 84 and 168
- Serum Concentration of TestosteroneTime frame: Cohorts 1 and 2: Predose and at multiple time points post-dose from Days 1 to 85; Cohort 3: Predose and at multiple time points post-dose from Days 1 to 169
Locations
21 sites in 3 countries. Site status is shown where the registry gives one.
Urologic Surgeons of Arizona
Mesa, Arizona
East Valley Urology Center of Arizona
Queen Creek, Arizona
Bakersfield Institute of Advanced Urology
Bakersfield, California
Grimaldi Urology
Chula Vista, California
Valley Urology
Fresno, California
Tower Urology,
Los Angeles, California
Alarcon Urology Center
Montebello, California
Urology Center of Southern California
Murrieta, California
Biogenix Molecular
Miami, Florida
Icahn School of Medicine at Mount Sinai
New York, New York
Oregon Urology Institut
Springfield, Oregon
Carolina Urologic Research Center
Myrtle Beach, South Carolina
Urology of Virginia
Virginia Beach, Virginia
Summit Cancer Centers of North Spokane
Spokane, Washington
Centre Jean Perrin
Clermont-Ferrand, France
Centre Georges Francois Leclerc
Dijon, France
CHU de Nantes - Hôtel Dieu
Nantes, France
Hospital Universitario Vall d'Hebron
Barcelona, Spain
Hospital Clinic Barcelona
Barcelona, Spain
Hospital Clinico San Carlos
Madroñera, Spain
Instituto Valenciano de Oncologia
Valencia, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.